Skip to main content

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Agency: National Institutes of Health

Assistance Listings
  • 93.310 -- Trans-NIH Research Support

Forecasted opportunityLast Updated: Aug 5, 2026

Important dates

  • Forecasted post date: October 1, 2026
  • Forecasted application due date: February 15, 2027
  • Forecasted award date: December 1, 2027
  • Forecasted project start date: December 1, 2027
  • Fiscal Year: 2028

Award details

  • Expected project funding: $8,000,000
  • Expected awards: 10

Award min.

Not specified

Award max.

$500,000

  • Funding opportunity number:RFA-RM-28-006
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: August 5, 2026
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

The NIH Common Fund, in partnership with other NIH Institutes and Centers, plans to issue Notices of Funding Opportunity (NOFOs) for the RNomics program, which seeks to develop tools for studying the full set of RNA molecules (the RNome) in cells and tissues. The program will support technologies and resources that enable integrated analysis of RNA sequences, modifications, structures, locations, interactions, and functions to advance understanding of health and disease. RNomics includes four initiatives: technology enhancement centers, transformative technologies, molecular standards, and a coordinating center. Applications are not being solicited at this time. This notice is being provided to give potential applicants time to develop meaningful collaborations and strong projects. 

This NOFO will support the transformative technologies initiative. These phased projects will develop new experimental and computational RNA technologies that address major limitations of current methods. Projects will focus on early-stage, high-risk ideas not yet demonstrated at scale or in biologically relevant systems. Priority areas include tools to sequence RNA, detect modifications, study RNA function, and analyze RNA across molecules, cells, and tissues. Projects that successfully complete Phase 1 milestones will be evaluated for transition to Phase 2. Phase 2 projects are expected to deliver validated tools for community use.

Eligibility

Government

  • Special district governments
  • County governments
  • Federally recognized Native American tribal governments
  • City or township governments
  • Public and Indian housing authorities
  • State governments

Business

  • For-profit organizations other than small businesses
  • Small businesses

Nonprofit

  • Nonprofits non-higher education without 501(c)(3)
  • Nonprofits non-higher education with 501(c)(3)
  • Other Native American tribal organizations

Education

  • Public and state institutions of higher education
  • Independent school districts
  • Private institutions of higher education

Miscellaneous

  • Other

Additional information on eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Documents

No documents are currently available.

Agency contact information

Email: cfrnomics@od.nih.gov

cfrnomics@od.nih.gov

Common Fund RNomics Program Please contact via e-mail.

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov